June 18, 2013 at 10:36 AM EDT
Investor Alert: Holzer Holzer & Fistel, LLC Advises Investors of Upcoming Deadlines in Shareholder Litigation Involving Delcath Systems, Inc., Amyris, Inc., Nam Tai Electronics, Inc. and Accretive Health, Inc.

Holzer Holzer & Fistel LLC reminds investors of upcoming deadlines for applications to serve as lead plaintiff in securities class action lawsuits against Delcath Systems, Inc. (DCTH), Amyris, Inc. (AMRS), Nam Tai Electronics, Inc. (NTE) and Accretive Health, Inc. (AH).

Investors that suffered significant losses investing in any of these companies during the specified times who are interested in potentially serving as lead plaintiff in the respective class actions are encouraged to contact Michael I. Fistel, Jr., Esq. (mfistel@holzerlaw.com) or Marshall P. Dees, Esq. (mdees@holzerlaw.com) by email or via toll-free telephone at (888) 508-6832 to discuss their legal rights.

A lead plaintiff is a representative party appointed by the court to act on behalf of other class members in directing the litigation. Any member of the purported class may move the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.

Delcath Systems Inc.

A class action lawsuit has been filed on behalf of investors who purchased Delcath (NASDAQ: DCTH) common stock between April 21, 2010 and May 2, 2013, inclusive, alleging the company violated the federal securities laws by, among other things, misrepresenting the status of its New Drug Application for the commercial sale of its Melblez Kit.

The deadline to seek appointment as lead plaintiff in this lawsuit, which is pending in the United States District Court for the Eastern District of Pennsylvania, is July 8, 2013. More information about the lawsuit and the firm are available at www.holzerlaw.com.

Amyris, Inc.

A class action lawsuit has been filed on behalf of investors who purchased Amyris, Inc. (NASDAQ: AMRS) common stock between April 29, 2011 and February 8, 2012. The lawsuit alleges the company violated the federal securities laws by issuing false and misleading statements regarding Amyris’s ability to commercially produce Biofene.

The deadline to seek appointment as lead plaintiff in this lawsuit, which is pending in the United States District Court for the Northern District of California, is July 15, 2013. More information about the lawsuit and the firm are available at www.holzerlaw.com.

Nam Tai Electronics

A class action lawsuit has been filed on behalf of investors who purchased securities of Nam Tai Electronics (NYSE: NTE) between August 6, 2012 and April 26, 2013. According to the complaint, Nam Tai made false and misleading statements to investors during that time regarding demand for its products and its ability to withstand competition and volatility in the market for liquid crystal display modules.

The deadline to seek appointment as lead plaintiff in this matter, which is pending in the United States District Court for the Southern District of New York, is July 16, 2013. More information about the lawsuit and the firm are available at www.holzerlaw.com.

Accretive Health, Inc.

A class action lawsuit has been filed on behalf of investors who purchased Accretive Health, Inc. (NYSE: AH) common stock between May 20, 2010 and February 26, 2013, inclusive, including purchases made pursuant to the company’s initial public offering. The complaint alleges that Accretive Health issued false and misleading financial statements that did not conform to Generally Accepted Accounting Principles. On February 26, 2013, Accretive announced that it would postpone the release of its financial results for the fourth quarter and full year 2012 because it was evaluating the timing of revenue recognition for its revenue cycle management agreements. The company’s stock price declined dramatically on the news.

The deadline to seek appointment as lead plaintiff in this lawsuit, which is pending in the United States District Court for the Northern District of Illinois, is July 19, 2013. More information about the lawsuit and the firm are available at www.holzerlaw.com.

About The Firm

Holzer Holzer & Fistel, LLC dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer Holzer & Fistel, LLC has paid for the dissemination of this promotional communication, and Michael I. Fistel, Jr. is the attorney responsible for its content.

Contacts:

Holzer Holzer & Fistel, LLC
Michael I. Fistel, Jr., Esq.
Marshall P. Dees, Esq.
888-508-6832 (toll-free)
mfistel@holzerlaw.com
mdees@holzerlaw.com
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here